Tag: B-cell NHL market outlook

B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment Dominated by Roche – GlobalData Plc There are 1.7 million diagnosed prevalent cases of B-cell non-Hodgkin’s lymphoma (B-cell NHL) in the 16 countries covered in GlobalData’s epidemiology B-Cell Non-Hodgkin Lymphoma (NHL) marketed […]